A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia
Objectives Acute myeloid leukemia (AML) is one of the common hematological diseases with low survival rates. Studies have highlighted the dysregulated expression of immune-related and exosome-related genes (ERGs) in cancers. Nevertheless, it remains to be determined whether combining these genes hav...
Saved in:
| Main Authors: | Zenghui Fang, Jiali Fu, Xin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2300855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Pretreatment Serum Indirect Bilirubin Levels With Prognostic and Therapeutic Value in Patients With Newly Diagnosed Acute Myeloid Leukemia
by: Chunfang Kong, et al.
Published: (2025-02-01) -
Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis
by: Yi Chen, et al.
Published: (2025-05-01) -
Significant prognostic improvement in elderly patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax: outcomes from a retrospective real-world analysis
by: Yi Chen, et al.
Published: (2025-12-01) -
6-month survival of patients with acute myeloid leukemia who received modified chemotherapy at Wahidin Sudirohusodo Hospital
by: Edwinda D. Ratu, et al.
Published: (2024-09-01) -
Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value
by: Yang Song, et al.
Published: (2025-06-01)